Compare A & SLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | SLF |
|---|---|---|
| Founded | 1999 | 1871 |
| Country | United States | Canada |
| Employees | N/A | 32151 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Advertising |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8B | 36.2B |
| IPO Year | 1999 | N/A |
| Metric | A | SLF |
|---|---|---|
| Price | $119.90 | $66.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 1 |
| Target Price | ★ $165.13 | $84.00 |
| AVG Volume (30 Days) | ★ 1.9M | 676.2K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | 0.82% | ★ 3.97% |
| EPS Growth | ★ 3.16 | N/A |
| EPS | ★ 4.57 | N/A |
| Revenue | ★ $4,472,000,000.00 | N/A |
| Revenue This Year | $8.03 | N/A |
| Revenue Next Year | $6.22 | $5.30 |
| P/E Ratio | $27.29 | ★ $14.79 |
| Revenue Growth | ★ 6.43 | N/A |
| 52 Week Low | $96.43 | $52.44 |
| 52 Week High | $160.27 | $69.67 |
| Indicator | A | SLF |
|---|---|---|
| Relative Strength Index (RSI) | 28.83 | 54.19 |
| Support Level | $115.37 | $60.96 |
| Resistance Level | $123.79 | $66.05 |
| Average True Range (ATR) | 3.37 | 1.42 |
| MACD | -0.27 | -0.22 |
| Stochastic Oscillator | 3.89 | 34.02 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 38% of adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 20% of the firm's adjusted earnings in 2024. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.1 trillion total assets under management or administration at the end of 2024 and represents around 34% of the firm's earnings.